
    
      The purpose of this study is to assess the effectiveness and safety of the THERMOCOOL®
      SMARTTOUCH™ catheter in the treatment of drug refractory symptomatic paroxysmal atrial
      fibrillation (PAF) undergoing CPVI.
    
  